Racial/ethnic disparities identified in ophthalmology trials

(HealthDay)—Black and Hispanic or Latinx participants are underrepresented in clinical trials for ophthalmology drugs, according to a study published online April 22 in JAMA Ophthalmology.

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *

The information on this site is of a general nature only and is not intended to address the specific circumstances of any particular individual or entity. It is not intended or implied to be a substitute for professional advice. Read more.